Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-site Intradermal Rabies Booster in HIV-infected Adults
NCT02547727Unknown
- Sponsor
- Queen Saovabha Memorial Institute
- Start
- Feb 2016
- Primary completion
- Dec 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Randomised, open-label trial of Rabies vaccine in rabies (2 arms), sponsored by Queen Saovabha Memorial Institute. Primary endpoint: Rabies neutralizing antibody titers at 2 weeks. Status: unknown.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02547727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547727.